Clinical Potential of Respirable Antisense Oligonucleotides (RASONs) in Asthma

Author： Ball H.A.   Sandrasagra A.   Tang L.   Van Scott M.   Wild J.   Nyce J.W.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.2, 2003-01, pp. : 97-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases

By Nyce J.W.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1149-1156

Informa Healthcare

Access to resources Recommend Favorite

Antisense oligonucleotides: local delivery enhances their therapeutic potential

By Nyce J.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 263-267

Informa Healthcare

Access to resources Recommend Favorite

Clinical pharmacokinetics of second generation antisense oligonucleotides

By Yu Rosie Z   Grundy John S   Geary Richard S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 2, 2013-02 ,pp. : 169-182

Informa Healthcare

Access to resources Recommend Favorite

Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides

By Dias N.   Stein C.A.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. : 263-269

Elsevier

Access to resources Recommend Favorite

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

By Henry S.P.   Danis R.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 277-291

Informa Healthcare

Access to resources Recommend Favorite